John Leonard is the founder of Intellia Therapeutics. Intellia Therapeutics has raised $197M in total funding. Latest round: IPO.
John Leonard is the president and CEO of Intellia Therapeutics, a biotech company founded in 2014 to leverage CRISPR technology. He leads the US-based firm headquartered in Cambridge, Massachusetts, which advanced through multiple funding rounds including an IPO in 2016.
Full founder directory · Investor directory · Company funding database · Fundraising library